VolkerWilhelmStieberMD
Radiation Oncology • Winston Salem, NCCentral Nervous System Cancer, Thoracic Cancer
Physician
Dr. Stieber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Silas Creek Pkwy
Winston Salem, NC 27103Phone+1 336-718-5095Fax+1 336-718-9895- Is this information wrong?
Summary
- Dr. Volker Stieber is a radiation oncologist in Winston Salem, NC and is affiliated with the Novant Health Cancer Institute at Forsyth Medical Center. He is the IRB Chair and the Neuro-Oncology Council Co-Chair. He specializes in central nervous system tumors, thoracic oncology, and radiotherapy for benign conditions.
Education & Training
Mayo Clinic College of Medicine1998 - 2000
Medical University of South CarolinaResidency, Radiation Oncology, 1995 - 1998
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 1994 - 1995
Loma Linda University School of MedicineClass of 1994
University of CaliforniaBA, Biology & English, 1984 - 1988
Certifications & Licensure
SC State Medical License 1996 - 2025
NC State Medical License 2000 - 2024
CA State Medical License 1997 - 2002
FL State Medical License 1998 - 2002- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases Start of enrollment: 2004 Jan 01
- Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2003 Oct 01
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.Batchelor, T., Won, M., Chakravarti, A., Hadjipanayis, C., Shi, W., Ashby, L., Stieber, V., Robins, H., Gray, H., Voloschin, A., Fiveash, J., Robinson, C., Chamarthy, ...> ;Neuro-Oncology Advances. 2023 Oct 11
- 1 citationsGermline polymorphisms inassociated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M Wendland, Emad F Youssef, Volker W S...> ;Neuro-Oncology Advances. 2022 Oct 22
- 1 citationsOptically guided linac radiosurgery with a Leksell head frame as an adjunct to Gamma Knife treatment.Kenneth E. Ekstrand, William H. Hinson, W.T. Kearns, J. Daniel Bourland, Allan F. deGuzman, Kevin P. McMullen, Volker W. Stieber> ;Technology in Cancer Research & Treatment. 2007 Apr 1
- Join now to see all
Press Mentions
Dr. Volker W. Stieber, MD, Joins Vivacitas' Neuro-Oncology Advisory BoardFebruary 7th, 2022
Committees
- Leader, Novant Health Cancer Institute GWSM Neuro-Oncology Council 2019 - Present
- Chair, IRB, Novant Health Forsyth Medical Center
Professional Memberships
- Member
- Member
- Society for Neuro-Oncology (SNO)Member
Other Languages
- German
Hospital Affiliations
Novant Health Forsyth Medical CenterWinston Salem, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
